CClinicalTrials.gg
CompletedNCT03592420PRECISAUpdated Jul 19, 2018

PRE.C.I.S.A - Fall Prevention and Promotion of Active and Healthy Aging

An interventional study of Interdisciplinary multicomponent interventions and Usual care in Fall, Aging and Parkinson Disease, sponsored by Azienda Unita' Sanitaria Locale Di Modena. Completed at 2 sites in Italy. Open to participants aged 65 Years and older. Per ClinicalTrials.gov, last updated 2018-07-19.

Sponsored by Azienda Unita' Sanitaria Locale Di Modena · Not applicable, Interventional, and Prevention

From the registry’s dates

  • Registered 3 years 5 months after the study started (first participant enrolled Dec 2014, registered Jun 2018).
Phase
Not applicable
Study type
Interventional
Enrollment
366
Allocation
Randomized
Ages
65 Years and older
Sex
All
01

Study summary

Randomized Controlled Trial (RCT) aiming at assessing the efficacy of an interdisciplinary multi-component and personalized multi-factorial intervention for reducing falls at one year post-enrolment in comparison to the usual care in a sample of community dwelling elderly (age ≥65 years), with or without Parkinson's Disease and/or previous Stroke.

Read the detailed description

BACKGROUND: Current literature on fall prevention for community-dwelling elderly who are at risk of falling suggests that: 1) either single, multicomponent or multifactorial interventions are effective at preventing falls; 2) elderly at risk of falling with Parkinson's Disease (PD) and previous Stroke, although having an even greater risk of falling, are often excluded by these interventions; 3) often, present screening methods for risk of falling do not allow the early identification of subjects at risk before the first fall.

AIMS

  • To compare the efficacy of an interdisciplinary multicomponent and personalized multifactorial intervention aiming at reducing falls in comparison to the usual care, in a sample of community dwelling elderly, with or without Parkinson's Disease and/or previous Stroke, within the context of an RCT.
  • To improve the accuracy of screening tests for risk of falling by using wearable inertial sensors.
  • To develop a reduced set of clinical and instrumental indicators, to be utilized as a quick and reliable screening tests in outpatients clinics.

METHODS: multicenter, randomized controller trial, with blind assessments on pretest, postest and on one-year follow-up.

POPULATION: community-dwelling elderly (aged ≥65 years) with age-related or neurological condition-related (Parkinson's Disease and/or Stroke) risk of falling.

INTERVENTION: interdisciplinary multi-component (group-based exercise; home-based exercise; increasing knowledge/education; home safety interventions) and personalized multi-factorial interventions (assessment and treatment of individual fall risk factors) CONTROL: structured information about participant's own personal risk factors given to the family doctor.

OUTCOMES: The primary endpoint is the fall rate at one year in both groups. The secondary endpoint is the fall risk at one year.

EXPECTED RESULTS: in the intervention group, a significant reduction in the number of total fall is expected, together with decreases indicators of utilization of acute health services because of falls. At three months, it is expected a significant improvement of functioning (motor functions, activity and participation) and health quality indicators.

02

Conditions studied

  • Fall
  • Aging
  • Parkinson Disease
  • Stroke

Browse trials for

Keywords

  • Accidental falls
  • Clinical trial
  • Aged
  • Parkinson's Disease
  • Stroke
  • Exercise
  • Education
03

In context

Parkinson Disease

4,487 studies on the registry are indexed under Parkinson Disease; 1,082 are open to participants now.

This study's enrollment of 366 is above the median of 40 across 3,294 interventional studies indexed under Parkinson Disease.

Browse Parkinson Disease studies →

Lead sponsor

Azienda Unita' Sanitaria Locale Di Modena is the lead sponsor of 4 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
65 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  1. Community-dwelling elderly (aged ≥65 years)
  2. Moderate to high fall risk, either associated to aging or to neurological diseases as Parkinson's Disease and stroke.
  3. Ability to walk 10 meters without assistance (walking aid permitted)
  4. Informed consent to participation

Exclusion criteria

Exclusion Criteria:

  1. Whatever concurrent medical condition which may constitutes a contraindication to physical exercise
  2. Known cognitive decline or an established diagnosis of dementia (mini mental score >24) or an evident cognitive decline on pre-enrolment which would be likely to impair the ability of comprehension of simple instructions and / or of collaborating
  3. Severe hearing impairment, so that a subject will not understand less than 80% of ordinary conversation with/or without hearing aids.
  4. Severe hypovision, not counteracted by lenses, which will limit the patient in executing at least one activity of daily living (for instance, necessity of assistance for walking because of visual deficit).
  5. Severe aphasia or visuo-spatial deficits, to the extent that these impairments will limit significantly the ability to comprehend (orally or visually) simple instructions.
  6. Acute vertigo or dizziness lasting less than 3 months
  7. Regular participation to other exercise program that it is likely to challenge balance, including physical therapy.
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
366 participants (actual)

Study arms

  • Experimental
    Interdisciplinary interventions

    Multicomponent interventions * On-site supervised group exercise program (11 weeks) * Educational / behavioral sessions addressing specific behavioral and environmental risk factors for falls delivered by trained health professionals (11 sessions in total) * Home visits for suggestion and implementations of safety interventions aiming at reducing environmental hazards * Home-based exercise program: Personalized multi-factorial interventions: patients will have geriatric, neurology and physiatrist outpatient referrals to assess and treat individual risk factors. Personalized multi-factorial interventions. Patients will have geriatric, neurology and physiatrist outpatient referrals to assess and treat individual risk factors

    Behavioral: Interdisciplinary multicomponent interventions

  • Active comparator
    Usual care

    Usual care: after pre-test assessment and randomization, participants in the control group will be given a structured booklet with detailed information about participant's own personal risk factors (fall risk profile) to be given to the family doctor, together with an information booklet on fall risk factors and their prevention.

    Behavioral: Usual care

Interventions

  • BehavioralInterdisciplinary multicomponent interventions
  • BehavioralUsual care

    standard care

06

What researchers measure

Primary outcomes

  1. Fall rate at 12 months from enrolment

    The primary endpoint will be the total number of falls (fall rate) occurred in each arm within 12 months from enrolment. This endpoint will be recorded by participants in a fall diary (which will be collected from each participant at month 12). Recorded information in the fall diary will be monitored monthly with follow-up calls

    Time frame: Months 1 - Months 12

Secondary outcomes

  1. Risk of falling at 12 months from enrolment

    This secondary endpoint will be calculated as the number of patients with at least one falls within 12 months from enrolment. This endpoint will be recorded by participants in a fall diary (which will be collected from each participant at month 12). Recorded information in the fall diary will be monitored monthly with follow-up calls

    Time frame: Months 1 - Months 12

  2. Percentage of falls associated to hospital admission at 12 months from enrolment

    This secondary endpoint will be recorded by participants in a fall diary (which will be collected from each participant at month 12). Recorded information in the fall diary will be monitored monthly with follow-up calls

    Time frame: Months 1 - Months 12

  3. Severity of the fall

    This secondary endpoint will be recorded by participants in a fall diary (which will be collected from each participant at month 12). Recorded information in the fall diary will be monitored monthly with follow-up calls

    Time frame: Months 1 - Months 12

  4. Mortality attributable to fall

    This secondary endpoint will be recorded by participants in a fall diary (which will be collected from each participant at month 12). Recorded information in the fall diary will be monitored monthly with follow-up calls

    Time frame: Months 1 - Months 12

  5. Fall-free interval time

    This secondary endpoint will be recorded by participants in a fall diary (which will be collected from each participant at month 12). Recorded information in the fall diary will be monitored monthly with follow-up calls

    Time frame: Months 1 - Months 12

  6. Total number of A&E accesses attributable to falls

    This secondary endpoint will be recorded by participants in a fall diary (which will be collected from each participant at month 12). Recorded information in the fall diary will be monitored monthly with follow-up calls

    Time frame: Months 1 - Months 12

  7. Risk of A&E access attributable to falls

    This secondary endpoint will be recorded by participants in a fall diary (which will be collected from each participant at month 12). Recorded information in the fall diary will be monitored monthly with follow-up calls

    Time frame: Months 1 - Months 12

  8. Length of stay as inpatient attributable to falls

    This secondary endpoint will be recorded by participants in a fall diary (which will be collected from each participant at month 12). Recorded information in the fall diary will be monitored monthly with follow-up calls

    Time frame: Months 1 - Months 12

07

Study locations

2 sites
  • Nuovo Ospedale Civile Sant'Agostino Estense
    Modena, 41121, Italy
  • Arcispedale "Santa Maria Nuova" di Reggio Emilia
    Reggio Emilia, 42121, Italy
08

References and documents

Publications

  • Gillespie LD, Robertson MC, Gillespie WJ, Sherrington C, Gates S, Clemson LM, Lamb SE. Interventions for preventing falls in older people living in the community. Cochrane Database Syst Rev. 2012 Sep 12;2012(9):CD007146. doi: 10.1002/14651858.CD007146.pub3. PubMed 22972103 ↗
  • Weiss A, Herman T, Plotnik M, Brozgol M, Giladi N, Hausdorff JM. An instrumented timed up and go: the added value of an accelerometer for identifying fall risk in idiopathic fallers. Physiol Meas. 2011 Dec;32(12):2003-18. doi: 10.1088/0967-3334/32/12/009. Epub 2011 Nov 17. PubMed 22094550 ↗
  • Schoene D, Wu SM, Mikolaizak AS, Menant JC, Smith ST, Delbaere K, Lord SR. Discriminative ability and predictive validity of the timed up and go test in identifying older people who fall: systematic review and meta-analysis. J Am Geriatr Soc. 2013 Feb;61(2):202-8. doi: 10.1111/jgs.12106. Epub 2013 Jan 25. PubMed 23350947 ↗
  • La Porta F, Lullini G, Caselli S, Valzania F, Mussi C, Tedeschi C, Pioli G, Bondavalli M, Bertolotti M, Banchelli F, D'Amico R, Vicini R, Puglisi S, Clerici PV, Chiari L; PRECISA Group. Efficacy of a multiple-component and multifactorial personalized fall prevention program in a mixed population of community-dwelling older adults with stroke, Parkinson's Disease, or frailty compared to usual care: The PRE.C.I.S.A. randomized controlled trial. Front Neurol. 2022 Sep 1;13:943918. doi: 10.3389/fneur.2022.943918. eCollection 2022. PubMed 36119666 ↗

Individual participant data

Plan to share: No

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 19, 2018, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03592420
Lead sponsor
Azienda Unita' Sanitaria Locale Di Modena
Collaborators
Azienda Ospedaliero-Universitaria di Modena, Azienda Unità Sanitaria Locale Reggio Emilia, Arcispedale Santa Maria Nuova-IRCCS
Responsible party
Sponsor
First posted
Jul 19, 2018
Start date
Dec 31, 2014
Primary completion
Dec 31, 2016
Completion
Jun 30, 2017
Last update
Jul 19, 2018

Study contacts

Fabio La Porta, MD
principal investigator · AZIENDA USL DI MODENA

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jul 2018. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion